Shu-Wei Chang

Prof. Shu-Wei Chang

Department of Civil Engineering, National Taiwan University, Taipei, Taiwan

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2019 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Closed access
SHShun-Chieh Hsu
Shun-Chieh Hsu
Shan-hui HsuShan-hui Hsu
Shan-hui Hsu
SCShu-Wei Chang
Shu-Wei Chang

24 September 2018 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
WKWen-Chin Ko
Wen-Chin Ko
CCCheuk Sing Choy
Cheuk Sing Choy
WLWei-Ning Lin
Wei-Ning Lin
SCShu-Wei Chang
Shu-Wei Chang
JLJian-Chiun Liou
Jian-Chiun Liou
Jia-Feng ChangJia-Feng Chang
Jia-Feng Chang
Background: Interactions and joint effects of galectin-3 and vascular cell adhesion molecule 1 (VCAM-1) on risks of all-cause and cardiovascular (CV) mortality remain unclear in patients with maintenance hemodialysis (MHD). Methods: Unadjusted and adjusted hazard ratios (aHRs) of mortality risks were analyzed between higher and lower concentration groups of serum galectin-3 and VCAM-1. The modification effect between serum galectin-3 and VCAM-1 on mortality risk was investigated using an interaction product term. Results: During follow-up, galectin-3 and VCAM-1 were associated with incremental risks of all-cause mortality (aHR: 1.038 (95% confidence interval (CI): 1.001–1.077) and 1.002 (95% CI: 1.001–1.003), respectively). Nonetheless, VCAM-1 but not galectin-3 predicted CV mortality (aHR: 1.043 (95% CI: 0.993–1.096) and 1.002 (95% CI: 1.001–1.003), respectively). In the interaction analysis, patients with combined higher galectin-3 (>29.5 ng/mL) and VCAM-1 (>1546.9 ng/mL) were at the greatest risk of all-cause and CV mortality (aHR: 4.6 (95% CI: 1.6–13.4), and 4.2 (95% CI: 1.3–14.4), respectively). The interactions between galectin-3 and VCAM-1 with respect to all-cause and CV mortality were statistically significant (p < 0.01 and < 0.05, respectively). Conclusion: Galectin-3 and VCAM-1 could serve as a promising dual biomarker for prognostic assessment, considering their joint effects on pathogenesis of leukocyte trafficking and atherothrombosis.

Verified
Journal Article
Open access
PDF file
Jia-Feng ChangJia-Feng Chang
Jia-Feng Chang
JYJih-Chen Yeh
Jih-Chen Yeh
CHChun-Ta Ho
Chun-Ta Ho
SLShih-Hao Liu
Shih-Hao Liu
CHChih-Yu Hsieh
Chih-Yu Hsieh
WLWei-Ning Lin
Wei-Ning Lin
Obesity is associated with metabolic endotoxemia, reactive oxygen species (ROS), chronic inflammation, and obese kidney fibrosis. Although the fat–intestine–kidney axis has been documented, the pathomechanism and therapeutic targets of obese kidney fibrosis remain unelucidated. To mimic obese humans with metabolic endotoxemia, high-fat-diet-fed mice (HF group) were injected with lipopolysaccharide (LPS) to yield the obese kidney fibrosis–metabolic endotoxemia mouse model (HL group). Therapeutic effects of ROS, cytosolic phospholipases A2 (cPLA2) and cyclooxygenase-2 (COX-2) inhibitors were analyzed with a quantitative comparison of immunohistochemistry stains and morphometric approach in the tubulointerstitium of different groups. Compared with basal and HF groups, the HL group exhibited the most prominent obese kidney fibrosis, tubular epithelial lipid vacuoles, and lymphocyte infiltration in the tubulointerstitium. Furthermore, inhibitors of nonspecific ROS, cPLA2 and COX-2 ameliorated the above renal damages. Notably, the ROS-inhibitor-treated group ameliorated not only oxidative injury but also the expression of cPLA2 and COX-2, indicating that ROS functions as the upstream signaling molecule in the inflammatory cascade of obese kidney fibrosis. ROS acts as a key messenger in the signaling transduction of obese kidney fibrosis, activating downstream cPLA2 and COX-2. The given antioxidant treatment ameliorates obese kidney fibrosis resulting from a combined high-fat diet and LPS—ROS could serve as a potential therapeutic target of obese kidney fibrosis with metabolic endotoxemia.

Verified
Journal Article
Open access
PDF file
KCKun-Lin Chen
Kun-Lin Chen
DLDeng Li
Deng Li
TLTing-Xuan Lu
Ting-Xuan Lu
SCShu-Wei Chang
Shu-Wei Chang
CD44 is widely expressed in most vertebrate cells, whereas the expression of CD44v6 is restricted to only a few tissues and has been considered to be associated with tumor progression and metastasis. Thus, CD44v6 has been recognized as a promising prognostic biomarker and therapeutic target for various cancers for more than a decade. However, despite many experimental studies, the structural dynamics and differences between CD44s and CD44v6, particularly in their stem region, still remain elusive. Here, a computational study was conducted to address these problems. We found that the stem of CD44s adopted predominantly two conformations, one featuring antiparallel β-sheets and the other featuring parallel β-sheets, whereas the stem of CD44v6 adopted mainly one conformation with relatively highly suppressed β-sheet contents. Moreover, Phe215 was found to be essential in the β-sheets of both CD44s and CD44v6. We finally found intramolecular Phe215–Trp224 hydrogen-bonding interactions and hydrophobic interactions with Phe215 that cooperatively drove conformational differences upon the addition of the v6 region to CD44. Our study elucidated the structural differences between the stem regions of CD44s and CD44v6 and thus can offer useful structural information for drug design to specifically target CD44v6 in promising clinical applications.

14 August 2017 in Advanced Engineering Materials
Verified
Journal Article
Closed access
PDF file
THTsung‐Hui Huang
Tsung‐Hui Huang
THTzu‐Hsuan Huang
Tzu‐Hsuan Huang
YLYang‐Shan Lin
Yang‐Shan Lin
CCChih‐Hsiang Chang
Chih‐Hsiang Chang
PCPo‐Yu Chen
Po‐Yu Chen
CCChuin-Shan Chen
Chuin-Shan Chen

14 September 2016 in Polymer Journal
Verified
Journal Article
Open access
SCShu-Wei Chang
Shu-Wei Chang
TMTsuyoshi Muto
Tsuyoshi Muto
TKTakeshi Kondo
Takeshi Kondo
MLMing-Jhih Liao
Ming-Jhih Liao
MHMasaki Horie
Masaki Horie
Polymer Journal, official journal of the Society of Polymer Science, Japan publishes high quality papers in all areas of polymer and macromolecular research.